X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AJANTA PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AJANTA PHARMA J.B.CHEMICALS/
AJANTA PHARMA
 
P/E (TTM) x 14.6 24.3 60.2% View Chart
P/BV x 2.3 10.0 23.1% View Chart
Dividend Yield % 0.2 0.6 28.0%  

Financials

 J.B.CHEMICALS   AJANTA PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
AJANTA PHARMA
Mar-16
J.B.CHEMICALS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3181,720 18.5%   
Low Rs2001,103 18.1%   
Sales per share (Unadj.) Rs148.0194.6 76.0%  
Earnings per share (Unadj.) Rs19.145.2 42.2%  
Cash flow per share (Unadj.) Rs23.950.3 47.6%  
Dividends per share (Unadj.) Rs0.508.00 6.3%  
Dividend yield (eoy) %0.20.6 34.1%  
Book value per share (Unadj.) Rs128.9132.0 97.7%  
Shares outstanding (eoy) m84.8288.77 95.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.77.3 24.1%   
Avg P/E ratio x13.631.2 43.4%  
P/CF ratio (eoy) x10.828.1 38.5%  
Price / Book Value ratio x2.010.7 18.8%  
Dividend payout %2.617.7 14.8%   
Avg Mkt Cap Rs m21,951125,299 17.5%   
No. of employees `0002.7NA-   
Total wages/salary Rs m1,8412,570 71.6%   
Avg. sales/employee Rs Th4,590.9NM-  
Avg. wages/employee Rs Th673.4NM-  
Avg. net profit/employee Rs Th592.1NM-  
INCOME DATA
Net Sales Rs m12,55117,275 72.7%  
Other income Rs m542166 325.7%   
Total revenues Rs m13,09317,442 75.1%   
Gross profit Rs m2,0555,807 35.4%  
Depreciation Rs m412451 91.5%   
Interest Rs m9649 195.7%   
Profit before tax Rs m2,0885,474 38.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,460 32.1%   
Profit after tax Rs m1,6194,014 40.3%  
Gross profit margin %16.433.6 48.7%  
Effective tax rate %22.526.7 84.2%   
Net profit margin %12.923.2 55.5%  
BALANCE SHEET DATA
Current assets Rs m7,7787,639 101.8%   
Current liabilities Rs m4,3582,715 160.5%   
Net working cap to sales %27.228.5 95.6%  
Current ratio x1.82.8 63.4%  
Inventory Days Days5543 126.5%  
Debtors Days Days8079 101.7%  
Net fixed assets Rs m5,7136,914 82.6%   
Share capital Rs m170177 95.9%   
"Free" reserves Rs m10,54711,442 92.2%   
Net worth Rs m10,93711,721 93.3%   
Long term debt Rs m0149 0.0%   
Total assets Rs m15,57414,814 105.1%  
Interest coverage x22.8112.9 20.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.81.2 69.1%   
Return on assets %11.027.4 40.1%  
Return on equity %14.834.2 43.2%  
Return on capital %20.046.5 42.9%  
Exports to sales %48.755.1 88.3%   
Imports to sales %7.16.0 117.9%   
Exports (fob) Rs m6,1159,527 64.2%   
Imports (cif) Rs m8891,038 85.6%   
Fx inflow Rs m6,16910,422 59.2%   
Fx outflow Rs m1,2851,678 76.6%   
Net fx Rs m4,8848,744 55.9%   
CASH FLOW
From Operations Rs m1,3973,264 42.8%  
From Investments Rs m-320-2,093 15.3%  
From Financial Activity Rs m-1,196-1,186 100.9%  
Net Cashflow Rs m-102-15 691.2%  

Share Holding

Indian Promoters % 55.4 73.8 75.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 1.6 218.7%  
FIIs % 3.9 7.6 51.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.0 217.6%  
Shareholders   30,437 20,968 145.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   WYETH LTD  PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  SUN PHARMA  IPCA LABS  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Down Around 1%; Telecom & Metal Stocks Decline(01:30 pm)

Indian share markets are trading in the red presently. Sectoral indices are trading in the red with stocks in the telecom sector and metal sector witnessing maximum selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 19, 2018 02:01 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - SUN PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS